MedPath

A Preliminary Randomized Controlled Trial Examining the Effects of Rumination Focused Cognitive Behavioral Therapy on Autism Spectrum Disorder and their Brain Basis

Phase 1
Recruiting
Conditions
Autism Spectrum Disorder
Registration Number
JPRN-UMIN000040092
Lead Sponsor
Hamamatsu University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

1)Those who have a high urgency for treatment, such as an imminent suicide attempt. 2)Patients with intracranial occupational lesions or vascular lesions such as cerebral infarction. 3)Patients with neurological diseases such as epilepsy. 4)MRI contraindicated. 5)Pregnancy or possible pregnancy.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in the Hamilton Depression Rating Scale (HDRS) 17-item version between baseline and endpoint.
Secondary Outcome Measures
NameTimeMethod
1.Resting state functional Magnetic Resonance Image(rs-fMRI) 2.Magnetic Resonance Image structure imag:T1- and T2-weighted images 3.Proton magnetic resonance spectroscopy(1H-MRS) 4.Beck Depression Inventory(BDI) 5.Ruminative Responses Scale(RRS) 6.State-Trait Anxiety Inventory(STAI) 7.Autism Spectrum Quotient-Japan(AQ-J) 8.Repetitive Behavior Scale-Revised(RBS-R)
© Copyright 2025. All Rights Reserved by MedPath